Free tool
Cell therapy stocks
We cover 2 companies grouped under the Cell therapy theme. The median market value in the group is $13.70M. Across the group, the median move over the past trading day is +3.01%. Price change over the past year runs from −83.3% to −43.6% across the middle 80 percent of the group, with a median of −63.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 86 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| BCDA | BioCardia, Inc. | $18.02M | Micro cap | −38.66% |
| FBLG | FibroBiologics, Inc. | $9.39M | Micro cap | −88.25% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.